Trial intelligence / Profile preview

Guifu Dihuang pill combined with ACEI/ARB for early diabetic nephropathy

ChiCTR-TRC-12002822Phase 4Completed

Sponsor
Nanfang Hospital, Southern Medical University
Start
Dec 2010
Countries
1
01

Overview

Phase 4, open-label trial of guifu dihuang pill in diabetic glomerulosclerosis (2 arms), sponsored by Nanfang Hospital, Southern Medical University. Primary endpoint: Urine microalbumin excretion rate over 24 hours. Started Dec 2010; status: completed.

02

Drugs

guifu dihuang pill
03

Conditions

diabetic glomerulosclerosis

Beyond the preview

Go deeper on ChiCTR-TRC-12002822.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-12002822.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call